Aprea Therapeutics Free Cash Flow (Quarterly) Trends

Aprea Therapeutics Inc (APRE)

5.50 -0.11 (-1.96%) USD | NASDAQ | Apr 19, 16:00

5.50 0.00 (0.00%) After-Hours: 16:17

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-3.747M
September 30, 2023	-2.328M
June 30, 2023	-3.217M
March 31, 2023	-2.979M
December 31, 2022	-4.020M
September 30, 2022	-6.593M
June 30, 2022	-8.903M
March 31, 2022	-5.495M
December 31, 2021	-10.18M
September 30, 2021	-8.233M

Date	Value
June 30, 2021	-7.752M
March 31, 2021	-11.52M
December 31, 2020	-13.22M
September 30, 2020	-11.42M
June 30, 2020	-9.636M
March 31, 2020	-7.554M
December 31, 2019	-14.76M
September 30, 2019	-2.804M
June 30, 2019	-4.982M
March 31, 2019	-4.197M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-14.76M

Minimum

Dec 2019

-2.328M

Maximum

Sep 2023

-7.334M

Average

-7.554M

Median

Mar 2020

Free Cash Flow (Quarterly) Benchmarks